Mesoblast Completes Treatment in Pivotal Low Back Pain Trial as Phase 3 Readout Approaches
Importance · 4/5Sources · 1
What happened
Australian biotech Mesoblast has completed the treatment phase of its pivotal low back pain trial.
Why it matters
This milestone is significant as the phase 3 readout approaches.
Notes
None
Sources
Mesoblast completes treatment in pivotal low back pain trial as phase 3 readout approaches - BioPharmaDispatch
pharmadispatch.com · Published: Aug 17, 2026, 8:30 AM